Clinical trial
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
NCT00486980 · BioCryst Pharmaceuticals, Industry · Withdrawn
Key facts
| NCT number | NCT00486980 |
|---|---|
| Title | Intramuscular Peramivir for the Treatment of Uncomplicated Influenza |
| Official title | A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAMUSCULAR PERAMIVIR IN SUBJECTS WITH UNCOMPLICATED ACUTE INFLUENZA |
| Lead sponsor | BioCryst Pharmaceuticals, Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Peramivir 150mg, Peramivir 300mg |
| First posted | Jun 15, 2007 |
| Last update posted | Jan 30, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: